Newsletters

Newsletter 3: OA/RA Drug Development
Inflamation and Synovitis, YKL-40, PIINP, CRP
Click here for Newsletter 3

Newsletter 4: OA/RA Drug Development
Bone Turnover Markers in Joint Disease
Click here for Newsletter 4

Newsletter 5: Metabolic Syndrome
Biochemical Markers of Insulin-Resistant Dyslipidemia, RLPC (Remnant-like Particle Cholesterol)
Click here for Newsletter 5